Rumour: PCI Pharma Services looking for $1bn buyout says Reuters

By Staff Reporter

- Last updated on GMT

Rumour: PCI Pharma Services looking for $1bn buyout says Reuters

Related tags: Pci pharma services, Pharmacology

Drug packaging and clinical trial supply firm PCI Pharma Services is looking for a buyer according to Reuters.

The newswire reported that PCI’s private equity owner had asked bank RBC Capital Markets to find potential buyers last night, citing “people familiar with the matter​.”

PCI was established in 2012 after current majority owner Frazer Healthcare Partners bought Catalent Pharma Solutions’s packaging operations.

The firms other backers include QIC Global Private Equity, Greenspring Associates and Thomas, McNerney & Partners.

In the years since Frazier has expanded the business. In 2013, it bought AndersonBrecon,​ the packaging subsidiary of AmerisourceBergen, for $308m (€229m).

A year later​ it acquired Tredegar, Wales based contract development and manufacturing services firm Penn Pharmaceutical Services for £127m ($215m)

Also in 2014​ PCI bought packaging and distribution firm Biotec Services International – based in Bridgend, Wales - citing demand for cold chain services from a growing injectable pharmaceutical market as the driver.

Frazier did not respond to a request for comment about the Reuters report.

Related news

Show more

Related products

show more

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Related suppliers

Follow us


View more